Merck & Co., Inc.

-

Assets, Funds, Holdings

Home | Sign Up | Log In
Message
Happy Holidays!! thanks for using AUM13F!!
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Merck & Co., Inc.
CIK #0000310158
CIK Period
0000310158
Sector Form 13F Holdings Value ($M)
Personalis Inc 92.1
Moderna Inc 63.7
Kymera Therapeutics Inc 33.7
Alector Inc 5.0
Evaxion Biotech A/S 3.0
Sutro Biopharma Inc 1.9
LAVA Therapeutics NV 1.5
Signal Genetics Inc 1.3
Xilio Therapeutics Inc 1.0
Eleven Biotherapeutics Inc 0.6
Bionomics Limited/Fi 0.1
Berry Only Inc 0.0
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Prev | Page 1 | Next
EDGAR Form CIK 2011 - 2025
10-K [0000310158]
10-Q [0000310158]
13F-HR [0000310158]
3 [0000310158]
4 [0000310158]
5 [0000310158]
8-K [0000310158]
SC 13D [0000310158]
SC 13G [0000310158]
Form 13D/13G Filer Form 13D/13G Subject Filed
Merck & Co Inc Personalis Inc [2024-12-23]
Merck & Co Inc Evaxion Biotech A/S [2024-01-23]
Merck & Co Inc 4D Pharma PLC [2022-02-02]
Merck & Co Inc Pandion Therapeutics Inc [2021-03-04]
Merck & Co Inc Yumanity Therapeutics Inc [2021-01-04]
Merck & Co Inc Arqule Inc [2019-12-16]
Merck & Co Inc NGM Biopharmaceuticals Inc [2019-04-09]
Merck & Co Inc Alector Inc [2019-02-14]
Merck & Co Inc Sutro Biopharma Inc [2018-10-04]
Merck & Co Inc Menlo Therapeutics Inc [2018-02-14]
View All
Form 3/4/5 Subject 2011 - 2025
Merck & Co., Inc.
Guindo Chirfi
Williams David Michael
Coe Mary Ellen
Glocer Thomas H
Seidman Christine E
Craig Pamela J.
Lavizzo-Mourey RISA J
Karsanbhai Surendralal Lanca
Baker Douglas M Jr
View All
Terms | Privacy | Guide
tony@aum13f.com